Evidence map›Paper›PMID 31876055›Full record

ArticlePediatric blood & cancer2020

Dexamethasone and neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.

Kevin R Krull

Open access · greenAbstract readComment
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kevin R KrullDepartment of Epidemiology and Cancer Control, Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-0476-7001
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
Risk for Psychopathology and Neurocognitive Impairment in Leukemia SurvivorsR01MH085849 · NIMH · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KRULL, KEVIN R · 2010 to 2014
$2.4M
Training in Pediatric Cancer Survivorship Outcomes and InterventionsT32CA225590 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Kevin R Krull · 2018 to 2026
$2.4M
NCI NIH HHS CA195547NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS T32 CA225590NCI NIH HHS U01 CA195547NIMH NIH HHS MH085849NIMH NIH HHS R01 MH085849
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DexamethasonePrecursor Cell Lymphoblastic Leukemia-LymphomaChildHumansSurvivorsDexamethasonechildhood leukemiadexamethasone exposureneurocognitive

Identifiers

PMID31876055
PMCPMC6980910
OpenAlexW2996789166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.